Structural Modifications of Neuroprotective Anti-Parkinsonian (−)-N6-(2-(4-(Biphenyl-4-yl)piperazin-1-yl)-ethyl)-N6-propyl-4,5,6,7-tetrahydrobenzo[d]thiazole-2,6-diamine (D-264): An Effort toward the Improvement of in Vivo Efficacy of the Parent Molecule

[Image: see text] In our overall goal to develop multifunctional dopamine D(2)/D(3) agonist drugs for the treatment of Parkinson’s disease (PD), we previously synthesized potent D(3) preferring agonist D-264 (1a), which exhibited neuroprotective properties in two animal models of PD. To enhance the...

Descripción completa

Detalles Bibliográficos
Autores principales: Modi, Gyan, Antonio, Tamara, Reith, Maarten, Dutta, Aloke
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Chemical Society 2014
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3983390/
https://www.ncbi.nlm.nih.gov/pubmed/24471976
http://dx.doi.org/10.1021/jm401883v

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3983390/
https://www.ncbi.nlm.nih.gov/pubmed/24471976
http://dx.doi.org/10.1021/jm401883v

Ejemplares similares